Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

I-MOVE-plus

Financiado

Cerrado

I MOVE Integrated Monitoring of Vaccines Effects in Europe a platform to measu...

I MOVE Integrated Monitoring of Vaccines Effects in Europe a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination s... ver más

31/10/2018

EPICONCEPT

8M€

Presupuesto del proyecto: 8M€

Líder del proyecto

EPICONCEPT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 32 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-10-31

PHC-17-2014: Comparing the effectiveness of exis...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

32 Participantes

EPICONCEPT

1.65M€ | Lider

Instituto Aragonés de Cienci...

73.75K€ | Participante

UNIVERSITY OF STRATHCLYDE

67.11K€ | Participante

CENTRE HOSPITALIER UNIVERSIT...

60.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

VITAL Vaccines and Infectious Diseases in the Ageing PopuLation 12M€ Cerrado

PID2021-124067OB-C21 APORTACIONES EMPIRICAS EN POLITICAS DE PREVENCION SANITARIA... 48K€ Cerrado

Vaccinesurvey Monitor population immunity against vaccine preventable dise... 1M€ Cerrado

VAX-TRUST Addressing vaccine hesitancy in Europe 3M€ Cerrado

END-VOC ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES:... 10M€ Cerrado

OPTIMUNISE Optimising the impact and cost effectiveness of child health... 4M€ Cerrado

Duración del proyecto: 42 meses Fecha Inicio: 2015-04-07
Fecha Fin: 2018-10-31

Líder del proyecto

EPICONCEPT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 8M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share validated methods to evaluate post marketing vaccine performances. The objectives are to identify, pilot test, and disseminate in EU the best study designs to measure, on a real time basis, VE (direct effect) and the VI of vaccination programmes (indirect and overall effect) against laboratory confirmed cases of influenza (types/subtypes) and pneumococcal disease (serotypes), and clinical outcomes. Cost effectiveness analysis will be conducted. Results will allow to understand factors affecting specific VE, the duration of protection of influenza and pneumococcal vaccines, the interaction between vaccines, the role of repeated vaccinations, the occurrence of serotype replacement (pneumococcus); identify vaccine types and brands with low VE; guide the decision of the WHO committees on vaccine strain selection (influenza); provide robust benefit indicators (VE and VI) and cost benefit and effectiveness results; guide vaccination strategies (schedules, doses, boosters). This EU member state collaboration will respond to questions that require studies based on large sample sizes and sharing of expertise that cannot be achieved by one country alone. It will allow the best methods to be used and results to benefit to all EU countries whatever their current public health achievements. Results will be shared with international partners.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores